Jha et al. (2017) found that higher concentrations of IL-17 prior to combination bupropion-SSRI treatment was associated with a greater reduction in depression severity following treatment, indicating that IL-17 and Th17 cell numbers may serve as an effective biomarker for antidepressant response [77]. This evidence concerns the gene IL17A and depressive symptom measurement.